Quantitatively monitoring acute ischemic stroke patients post recombinant tissue plasminogen activator treatment

BACKGROUND AND AIMS: Thrombolytic therapy is widely used to treat acute ischemic stroke (AIS) patients. As intracerebral hemorrhage is a life‐threatening complication of this therapy, monitoring the fibrinolytic and coagulation systems is imperative. However, existing studies on plasmin inhibitor co...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yonge, Ma, Jingting, Shi, Qiyang, Xin, Shimeng, Yu, Haojia, Liu, Zilong, Pang, Chunsong, Dong, Feng, Wang, Jinghan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752160/
https://www.ncbi.nlm.nih.gov/pubmed/33364440
http://dx.doi.org/10.1002/hsr2.218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752160/
https://www.ncbi.nlm.nih.gov/pubmed/33364440
http://dx.doi.org/10.1002/hsr2.218

Ejemplares similares